IDH2 and oncocytic adenoma: In contrast to expectations based on these studies, we observed a strong IDH2 expression by immunohistology in oncocytomas and to a lesser degree in eosinophilic/oncocytic variants of chromophobe carcinoma by TMA (Figure 3).